Back to all news
AI Model Enhances Prediction of Infection Risks from Oral Mucositis in Stem Cell Transplant Patients
Researchers developed an explainable AI tool that accurately predicts infection risks related to oral mucositis in hematopoietic stem cell transplant patients.
Key Details
- 1Patients with oral mucositis after HSCT are almost 4x more likely to develop serious infections.
- 2A new AI-driven nomogram using demographic and clinical features shows superior predictive accuracy versus traditional models.
- 3Explainable AI provided clinicians with rationale for predictions, enabling targeted preventive care.
- 4Meta-analysis identified high-risk groups and specific risk factors such as chemotherapy types, age, and kidney issues.
- 5Researchers are working towards broad clinical adoption, including validation for other adverse events in cancer therapy.
- 6Findings were recently published in the journal Cancers and presented at MASCC 2025.
Why It Matters
This work leverages advanced AI to proactively identify high-risk cancer patients, supporting multidisciplinary care and personalizing preventive strategies. Enhanced prediction of adverse events can improve outcomes, reduce complications, and optimize resource use in cancer therapy.
Source
EurekAlert
Related News
•EurekAlert
NIH-Backed AI Model Predicts Cancer Survival Using Single-Cell Data
Researchers have developed scSurvival, a machine learning tool that uses single-cell tumor data to accurately predict cancer patient survival and identify high-risk cell populations.
•EurekAlert
Deep Learning Pathomics Platform Improves Immunotherapy Prediction in Lung Cancer
A deep learning pathomics platform accurately predicts immunotherapy response in metastatic NSCLC using routine pathology slides.
•EurekAlert
AI Pathology Model Outperforms PD-L1 in Predicting NSCLC Immunotherapy Response
MD Anderson's Path-IO machine learning platform accurately predicts immunotherapy responses in metastatic non-small cell lung cancer, surpassing current biomarker standards.